Comparative Pharmacology
Head-to-head clinical analysis: AQUATENSEN versus DICURIN PROCAINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AQUATENSEN versus DICURIN PROCAINE.
AQUATENSEN vs DICURIN PROCAINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
AQUATENSEN (methylclothiazide) is a thiazide diuretic that inhibits the sodium-chloride cotransporter (NCC) in the distal convoluted tubule of the nephron, increasing excretion of sodium, chloride, and water, thereby reducing plasma volume and blood pressure.
Dicurin Procaine is a mercurial diuretic that inhibits sodium and chloride reabsorption in the proximal tubule and loop of Henle, leading to increased urine output. The procaine component provides local anesthetic effects.
1-2 mg orally once daily, titrated to blood pressure response; maximum dose 4 mg/day.
50-100 mg (as procaine penicillin G) intramuscularly once daily; severe infections: 100-200 mg IM every 12-24 hours.
None Documented
None Documented
Terminal elimination half-life is 8-12 hours (mean 10 h); clinically, allows twice-daily dosing
Terminal elimination half-life: 0.5-1.5 hours (short-acting local anesthetic). Clinically, repeated doses may lead to accumulation if hepatic or renal impairment exists.
Renal: 50% unchanged; Fecal: 20% (via bile); remainder as inactive metabolites
Renal excretion of unchanged drug and metabolites: 60-80% via glomerular filtration and tubular secretion; biliary excretion <5%.
Category C
Category C
Diuretic
Diuretic